Ken Kuang: When Fluid Dynamics Meets Life-Saving Surgery
Ken Kuang, President of Torrey Hills Technologies, LLC, Partner of StockFan App, Advisor at Unpress AI, shared a post on LinkedIn:
“When Fluid Dynamics Meets Life-Saving Surgery.
Traditional medicine tells us that stubborn blood clots—the ‘white clots’ rich in fibrin—are some of the hardest obstacles to clear during a stroke.
Current suction methods often fail because these clots are too tough to aspirate, leaving surgeons with few options.
Enter the Stanford ‘Milli-spinner.’
Researchers at Stanford Medicine and Engineering have developed a tiny, high-speed rotating device that doesn’t just ‘suck’ or ‘grab’—it re-engineers the clot in real-time.
The Engineering Breakthrough:
- Mechanical Shrinking: By spinning at up to 40,000 RPM, the device creates a localized ‘rubbing’ effect.
- The 5 percent Factor: It compresses a clot to just 5 percent of its original volume, squeezing out red blood cells and condensing the fibrin into a tiny, dense bead.
- Precision Aspiration: Once condensed, the ‘shrunk’ clot is easily vacuumed out without breaking into dangerous fragments.
In trials, this ‘cotton ball’ approach jumped the success rate for tough clots from 11 percent to 90 percent on the first pass.
It’s a masterclass in how mechanical engineering and fluid dynamics can solve biological bottlenecks.
This tech is now heading toward human trials and could soon be the gold standard for treating strokes, pulmonary embolisms, and even heart attacks.
What do you think?
Is the future of surgery less about ‘cutting’ and more about high-speed mechanical manipulation at the micro-scale?”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders